International Advisory Committee on Clinical Trials in Multiple Sclerosis 2023, ' Multiple sclerosis progression : time for a new mechanism-driven framework ', The Lancet Neurology, vol. 22, no. 1, pp. 78-88 . https://doi.org/10.1016/S1474-4422(22)00289-7
North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group, Magnetic Resonance Imaging in Multiple Sclerosis study group & Consortium of Multiple Sclerosis Centres 2021, ' 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis ', The Lancet Neurology, vol. 20, no. 8, pp. 653-670 . https://doi.org/10.1016/S1474-4422(21)00095-8